{
  "docId": "019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "docSlug": "c76f9a1cfbf11e27618f62d901587aa3",
  "documentTitle": "Alkermes | Results Presentation Deck | 22 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 22,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-e60e-740c-a4d1-b8dd6fcd421d/4",
  "deckHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d",
  "deckJsonHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d.json",
  "deckAnchorHref": "/decks/019de073-e60e-740c-a4d1-b8dd6fcd421d#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.61,
        "x": 0.34,
        "y": 0.31
      },
      "kind": "image",
      "text": "LYBALVI, ARISTADA, Vivitrol, VUMERITY",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "020b60fd-7c43-4b19-8afc-9aa50d362e66",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.22,
        "x": 0.07,
        "y": 0.62
      },
      "kind": "paragraph",
      "text": "Pipeline of novel development candidates designed to target significant unmet needs",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0cbe7fa3-fddd-4404-8fdf-692ae10a61fc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.22,
        "x": 0.07,
        "y": 0.33
      },
      "kind": "paragraph",
      "text": "Significant, diverse revenues with new growth opportunities",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f14784a-2e9b-4a42-a0e8-e08727c64a6d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.61,
        "x": 0.34,
        "y": 0.55
      },
      "kind": "table",
      "text": "Neuroscience: ALKS 2680 (Phase 1, Narcolepsy), HDAC Inhibitors (Preclinical, Neurology/neuropsychiatry). Oncology: Nemvaleukin Alfa (Phase 2/3, Advanced solid tumors), IL-12/IL-18 (Preclinical, Advanced solid tumors)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8bdb7a6d-03cd-4092-810b-30dfa32a0047",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.25,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "Alkermes Today",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ce5aab8-fc91-4d59-9e16-2e787e907f64",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "7029cfd3-6ab7-466f-ae08-b856be50fb01",
      "evidence": "table/data: Neuroscience: ALKS 2680 (Phase 1, Narcolepsy), HDAC Inhibitors (Preclinical, Neurology/neuropsychiatry)",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "3af63a15-1d0d-472b-a2e0-e73ec502977c",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The document presents Alkermes' current situation and key messages to highlight the need for strategic alternatives.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}